Reasons for explantation of totally implantable access ports: A multivariate analysis of 385 consecutive patients

Annals of Surgical Oncology

Volumn 15, Issue 4, 2008, Pages 1124-1129

  Fischer, Lars ^a   Knebel, Phillip ^a   Schröder, Steffen ^a   Bruckner, Thomas ^a   Diener, Markus K ^a   Hennes, Roland ^a   Buhl, Klaus ^a   Schmied, Bruno ^a   Seiler, Christoph M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chemotherapy; Explantation; Infection; Surgery; TIAP

Indexed keywords

ADOLESCENT; ADULT; AGED; BENIGN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; POSTOPERATIVE INFECTION; POSTOPERATIVE THROMBOSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; CATHETERS, INDWELLING; COHORT STUDIES; DEVICE REMOVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 40549135983     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9783-z     Document Type: Conference Paper

References (29)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602-6
2. Seiler CM, Frohlich BE, Dorsam UJ, et al. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 2006;93:24-9
3. Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-12
4. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-65
5. Ng F, Mastoroudes H, Paul E, et al. A comparison of Hickman Line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol) 2007; 19:551-6
6. Knaebel HP, Marten A, Schmidt J, et al. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma-CapRI: study protocol. BMC Cancer 2005;5:37
7. Wu AW, Xu GW, Wang HY, et al. Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev 2007;CD005047
8. Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998;9:767-73
9. Biffi R, Pozzi S, Pace U, et al. Is there a real advantage in utilizing central venous ports in oncology surgery? An analysis of the cost-effectiveness ratio. Tumori 2001;87:S74-5
10. Kock HJ, Pietsch M, Krause U, et al. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998;22:12-6
11. Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 2001;136:1050-3
12. Shetty PC, Mody MK, Kastan DJ, et al. Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 1997;8:991-5
13. Zieschang M, Erben B, Hoffler D, et al. The Demers atrial catheter: experience with a single-lumen silicone catheter as short- and long-term access for hemodialysis. Clin Nephrol 1995;44:113-7
14. Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-5
15. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55
16. International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood 1987;70:1718-21
17. Pagani O, Gelber S, Price K, et al. Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93. Ann Oncol 2004;15:1749-59
18. Hotta T, Takifuji K, Arii K, et al. Toxicity during L-LV/5FU adjuvant chemotherapy as a modified RPMI regimen for patients with colorectal cancer. Oncol Rep 2005;14:433-9
19. Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 2006;64:326-35
20. Carmeli Y, Castro J, Eliopoulos GM, et al. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother 2001;45:275-9
21. Aliyu SH, Enoch DA, Abubakar II, et al. Candidaemia in a large teaching hospital: a clinical audit. QJM 2006;99:655-63
22. Ozkocaman V, Ozcelik T, Ali R, et al. Bacillus spp among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect 2006;64:169-76
23. Prevention of vascular catheter associated infections. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2002:907-24
24. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-29
25. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999;281:261-7
26. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340:1-8
27. Gastmeier P, Zuschneid I, Geffers C. Antimicrobially impregnated catheters: An overview of randomized controlled trials. J Vasc Access 2003;4:102-10
28. Chiou PF, Chang CC, Wen YK, et al. Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin Nephrol 2006;65:419-22
29. Scalamogna A, Castelnovo C, De Vecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1991;18:674-7